Ocular Therapeutix, Inc
OCUL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001393434
In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Ocular Therapeutix, Inc changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 116 | 127 | +11 |
| Shares | 39.6M | 40.5M | +874.2K (+2.2%) |
| Value | $111.3M | $213.8M | +$102.5M (+92.1%) |
New holders (27)
Institutions that held Ocular Therapeutix, Inc at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (16)
Institutions that held Ocular Therapeutix, Inc at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Emerald Mutual Fund Advisers Trust | 680,588 | $1.91M |
| XTX Topco Ltd | 236,851 | $665.6K |
| State of Wisconsin Investment Board | 105,800 | $297.3K |
| Panagora Asset Management Inc | 38,757 | $108.9K |
| CSS LLC | 25,809 | $72.5K |
| Caption Management, LLC | 25,000 | $70.3K |
| Verition Fund Management LLC | 17,502 | $49.2K |
| Dynamic Technology Lab Private Ltd | 15,814 | $44.0K |
| Russell Investments Group, Ltd. | 13,561 | $38.1K |
| HSBC Holdings PLC | 11,940 | $32.9K |
| Centerpoint Advisors, LLC | 3,390 | $10.0K |
| IFP Advisors, Inc | 1,000 | $7.00K |
| Money Concepts Capital Corp | 1,000 | $2.81K |
| Quent Capital, LLC | 490 | $1.38K |
| Credit Suisse AG | 3 | $8 |
| Sofos Investments, Inc. | 3 | $6 |